HK1134820A1 - Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders - Google Patents

Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders

Info

Publication number
HK1134820A1
HK1134820A1 HK09111965.9A HK09111965A HK1134820A1 HK 1134820 A1 HK1134820 A1 HK 1134820A1 HK 09111965 A HK09111965 A HK 09111965A HK 1134820 A1 HK1134820 A1 HK 1134820A1
Authority
HK
Hong Kong
Prior art keywords
androstenes
androstanes
medicaments
cardiovascular disorders
azaheterocyclyl
Prior art date
Application number
HK09111965.9A
Other languages
English (en)
Chinese (zh)
Inventor
阿爾貝托‧切里
喬治‧費德里奇
亞歷山德拉‧貝尼基奧
朱塞佩‧比安基
帕特里夏‧法拉利
毛羅‧戈比尼
羅莎瑪麗亞‧米凱萊蒂
馬爾科‧波濟
皮耶羅‧恩里科‧斯科蒂
Original Assignee
西格馬-陶工業製藥重組有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 西格馬-陶工業製藥重組有限公司 filed Critical 西格馬-陶工業製藥重組有限公司
Publication of HK1134820A1 publication Critical patent/HK1134820A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
HK09111965.9A 2006-04-13 2009-12-18 Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders HK1134820A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06112605 2006-04-13
PCT/EP2007/053521 WO2007118830A1 (fr) 2006-04-13 2007-04-11 Dérivés azahétérocyclyle d'androstanes et d'androstènes comme médicaments contre des troubles cardio-vascualaires

Publications (1)

Publication Number Publication Date
HK1134820A1 true HK1134820A1 (en) 2010-05-14

Family

ID=37309533

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09111965.9A HK1134820A1 (en) 2006-04-13 2009-12-18 Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders

Country Status (16)

Country Link
US (1) US8536160B2 (fr)
EP (1) EP2004669B1 (fr)
JP (1) JP5438502B2 (fr)
KR (1) KR101411280B1 (fr)
CN (1) CN101466726B (fr)
AU (1) AU2007239516B2 (fr)
BR (1) BRPI0710613A2 (fr)
CA (1) CA2649173C (fr)
EA (1) EA015622B1 (fr)
ES (1) ES2403366T3 (fr)
HK (1) HK1134820A1 (fr)
MX (1) MX2008012943A (fr)
PL (1) PL2004669T3 (fr)
PT (1) PT2004669E (fr)
TW (1) TWI389917B (fr)
WO (1) WO2007118830A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010227644B2 (en) * 2009-03-23 2016-05-19 Cvie Therapeutics Limited 5-beta, 14-beta-androstane derivatives useful for the treatment of proteinuria, glomerulosclerosis and renal failure
WO2010149666A1 (fr) 2009-06-22 2010-12-29 Medexis S.A. Procédés pour traiter une néoplasie
WO2012013816A1 (fr) * 2010-07-30 2012-02-02 Medexis S.A. Composés et procédés pour le traitement de la néoplasie
CN103304623B (zh) * 2012-03-08 2015-05-20 华东师范大学 一种6β,19-环氧雄甾-3,17-二酮的合成方法
WO2017004485A1 (fr) 2015-07-02 2017-01-05 Raptor Pharmaceuticals Inc. Analogues de la cystéamine résistant à l'ado et utilisations de ceux-ci
CN105237455A (zh) * 2015-10-14 2016-01-13 湖南华腾制药有限公司 一种3-取代氮杂环丁烷的制备方法
CN108707180A (zh) * 2018-08-08 2018-10-26 齐齐哈尔医学院 3β-羟基-5α,8α-过氧雄甾-6-烯-17-(靛红取代)腙衍生物及制备和应用
ES2970792T3 (es) * 2019-10-09 2024-05-30 Windtree Therapeutics Inc Derivados de androstano con actividad como estimuladores puros o predominantemente puros de SERCA2A para el tratamiento de la insuficiencia cardíaca
CN113461771B (zh) * 2020-03-31 2022-09-30 南方科技大学 钠钾atp酶抑制剂的制备方法
CN115850359B (zh) * 2022-12-14 2024-06-11 梯尔希（南京）药物研发有限公司 一种孕二烯酮杂质i的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB868303A (en) 1956-09-08 1961-05-17 Syntex Sa New cyclopentanophenanthrene derivatives and process for the production thereof
BE589491A (fr) * 1959-04-10
US3210386A (en) 1961-01-09 1965-10-05 Upjohn Co 3-aminoethers of 3beta-hydroxy androstanes
BE621470A (fr) 1961-08-17
GB1175219A (en) 1967-06-22 1969-12-23 Ici Ltd 3-Aminoalkoxycarbonylmethylene Steroid Derivatives
US5144017A (en) * 1988-07-13 1992-09-01 University Of Manitoba Compounds that bind to digitalis receptor
DE19633349A1 (de) * 1996-08-19 1998-02-26 Sigma Tau Ind Farmaceuti Neue 6-Hydroxy- und 6-Oxo-androstan-Derivate, die auf das kardiovaskuläre System wirken und pharmazeutische Zusammensetzungen, die diese enthalten
US6100279A (en) 1998-11-05 2000-08-08 Schering Corporation Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
DE19906159A1 (de) * 1999-02-09 2000-08-10 Schering Ag 16-Hydroxyestratriene als selektiv wirksame Estrogene
FR2826011B1 (fr) 2001-06-14 2004-12-10 Oreal Nouveaux derives de la 7-oxo-dhea et utilisation cosmetique
FR2831440B1 (fr) 2001-10-25 2003-12-26 Oreal Composition cosmetique, renfermant un derive de la dhea et un agent apaisant
PL1689410T3 (pl) * 2003-11-26 2008-10-31 Bayer Schering Pharma Ag Sposób zapobiegania i leczenia nadciśnieniowych chorób serca za pomocą selektywnych estrogenów: 8ß-winylo-estra-1,3,5(10)-trien-3,17ß-diolu i 17ß-fluoro-9a-winylo-estra-1,3,5(10)-trien-3,16a-diolu

Also Published As

Publication number Publication date
AU2007239516A1 (en) 2007-10-25
PT2004669E (pt) 2013-04-18
EA015622B1 (ru) 2011-10-31
US20090275542A1 (en) 2009-11-05
CA2649173C (fr) 2013-11-19
CA2649173A1 (fr) 2007-10-25
CN101466726B (zh) 2014-09-24
KR20080109916A (ko) 2008-12-17
BRPI0710613A2 (pt) 2011-08-16
CN101466726A (zh) 2009-06-24
MX2008012943A (es) 2008-10-15
JP2009533391A (ja) 2009-09-17
EP2004669A1 (fr) 2008-12-24
AU2007239516A2 (en) 2009-01-08
TWI389917B (zh) 2013-03-21
TW200801032A (en) 2008-01-01
JP5438502B2 (ja) 2014-03-12
US8536160B2 (en) 2013-09-17
EP2004669B1 (fr) 2013-01-23
AU2007239516B2 (en) 2011-11-17
ES2403366T3 (es) 2013-05-17
PL2004669T3 (pl) 2013-06-28
KR101411280B1 (ko) 2014-06-24
WO2007118830A1 (fr) 2007-10-25
EA200870433A1 (ru) 2009-04-28

Similar Documents

Publication Publication Date Title
HK1134820A1 (en) Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
PL2040702T3 (pl) Zastosowanie pochodnych imidazolowych aktywujących ampk, sposób ich otrzymywania i kompozycje farmaceutyczne zawierające takie pochodne
HK1134821A1 (en) Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
HK1125044A1 (en) Methods and compositions for administration of iron
IL198847A (en) Process for making 2-imino-thiazolidine-4-on and several such histories
AU2007243282A8 (en) Compositions and methods for the treatment of cardiovascular disease
EP2032156A4 (fr) Compositions et procédés pour administrer de l'oxygène
IL192990A0 (en) Methods and compositions of targeted drug development
EP2007385A4 (fr) Composition cardiovasculaire et utilisation de ladite composition pour le traitement de la maladie d'alzheimer
PT2546253E (pt) Di-hidropirazolonas substituídas para o tratamento de doenças cardiovasculares e hematológicas
IL195161A0 (en) Pharmaceutical compositions of ropinirole and methods of use thereof
IL197877A (en) Uses of aminomethyl-4-imidazole derivatives for the preparation of medications and medications containing them
SI2057153T1 (sl) (3-ril-piperazin-1-il) derivati 6,7-dialkoksikuinazolin, 6,7-dialkoksiftalazin in 6,7-dialkoksiizokuinolin
IL206594A (en) The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations
PT2043610E (pt) Secagem de partículas contendo fármacos
WO2007081751A9 (fr) Compositions et procedes destines au traitement du cancer
WO2007101161A8 (fr) Méthodes et compositions servant au traitement de troubles gastro-intestinaux
IL193211A (en) Derivatives of Indzol-Troaril and pharmaceutical preparations containing them
IL196594A0 (en) Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors
PL2410047T3 (pl) Oksydoreduktaza i jej zastosowanie do redukcji sekodionu
PL2121025T3 (pl) Sposoby i kompozycje dla dostarczania czynnika terapeutycznego
EP2004216A4 (fr) Agent pour le traitement de troubles hormono-dépendants et utilisations de celui-ci
EP2320738A4 (fr) Dérivés d'aminothiazole substitués, compositions pharmaceutiques et leurs procédés d'utilisation
EP2129795A4 (fr) Procédés et compositions pour l'évaluation de la fonction et de troubles cardiovasculaires
EP2074258A4 (fr) Panneaux de fibres, leurs utilisations et leurs procédés de préparation

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190405